These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 2128050)
1. Whole-body distribution of iodine 123 metaiodobenzylguanidine in hypertrophic cardiomyopathy: significance of its washout from the heart. Taki J; Nakajima K; Bunko H; Simizu M; Muramori A; Hisada K Eur J Nucl Med; 1990; 17(5):264-8. PubMed ID: 2128050 [TBL] [Abstract][Full Text] [Related]
2. [Evaluation of hypertrophic cardiomyopathy with 123I-metaiodobenzylguanidine]. Nakajima K; Bunko H; Taki J; Shimizu M; Nanbu I; Muramori A; Matsunari I; Hisada K Kaku Igaku; 1990 Jan; 27(1):33-8. PubMed ID: 2338765 [TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of 123I-meta-iodobenzylguanidine (MIBG) uptake in hypertrophic cardiomyopathy. Nakajima K; Bunko H; Taki J; Shimizu M; Muramori A; Hisada K Am Heart J; 1990 Jun; 119(6):1329-37. PubMed ID: 2353619 [TBL] [Abstract][Full Text] [Related]
4. [Myocardial sympathetic activity and characteristics in hypertrophic cardiomyopathy: comparison with hypertensive hypertrophy]. Narita M; Kurihara T J Cardiol; 1996 Mar; 27(3):133-41. PubMed ID: 8865685 [TBL] [Abstract][Full Text] [Related]
5. Scintigraphic assessment of cardiac adrenergic innervation in patients with essential hypertension. Fujiwara Y; Hamada M; Shigematsu Y; Sumimoto T; Hamamoto K; Hiwada K J Cardiovasc Pharmacol; 1991; 17 Suppl 2():S148-50. PubMed ID: 1715467 [TBL] [Abstract][Full Text] [Related]
6. Cardiac 123I-MIBG reflects left ventricular functional reserve in patients with nonobstructive hypertrophic cardiomyopathy. Isobe S; Izawa H; Iwase M; Nanasato M; Nonokawa M; Ando A; Ohshima S; Nagata K; Kato K; Nishizawa T; Murohara T; Yokota M J Nucl Med; 2005 Jun; 46(6):909-16. PubMed ID: 15937299 [TBL] [Abstract][Full Text] [Related]
9. [Scintigraphic imaging of adrenergic structures of the heart with 123(I)-metaiodobenzylguanidine in cardiomyopathy]. Grötz J; Franitza R; Mödder G; Hossmann V Z Kardiol; 1988 May; 77(5):278-81. PubMed ID: 3407271 [TBL] [Abstract][Full Text] [Related]
10. Iodine-123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants. Glowniak JV; Turner FE; Gray LL; Palac RT; Lagunas-Solar MC; Woodward WR J Nucl Med; 1989 Jul; 30(7):1182-91. PubMed ID: 2661758 [TBL] [Abstract][Full Text] [Related]
11. [Myocardial imaging with 123I-metaiodobenzylguanidine (123I-MIBG) in essential hypertension: does the 123I-MIBG imaging have the ability to predict its prognosis?]. Narita M; Kurihara T; Murano K; Usami M; Honda M Kaku Igaku; 1994 Aug; 31(8):879-89. PubMed ID: 7933677 [TBL] [Abstract][Full Text] [Related]
12. [The characteristics of 123I-MIBG myocardial scintigraphy in patients with left ventricular pressure-overload diseases]. Kobayashi H; Momose M; Niki K; Yamazumi R; Iguchi N; Inoue S; Horie T; Kusakabe K; Hosoda S Kaku Igaku; 1995 Jun; 32(6):587-92. PubMed ID: 7674569 [TBL] [Abstract][Full Text] [Related]
13. [Myocardial adrenergic nerve activity in valvular diseases assessed by iodine-123-metaiodobenzylguanidine myocardial scintigraphy]. Imamura Y; Fukuyama T J Cardiol; 1997; 29 Suppl 2():21-6. PubMed ID: 9211099 [TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of I-123 MIBG myocardial scintigraphy for evaluating the severity of congestive heart failure]. Morozumi T; Ishida Y; Tani A; Sato H; Matsuyama T; Ozaki H; Hori M; Kitabatake A; Kamada T; Kimura K Kaku Igaku; 1991 Mar; 28(3):271-80. PubMed ID: 2046182 [TBL] [Abstract][Full Text] [Related]
16. Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy. Suwa M; Otake Y; Moriguchi A; Ito T; Hirota Y; Kawamura K; Adachi I; Narabayashi I Am Heart J; 1997 Mar; 133(3):353-8. PubMed ID: 9060806 [TBL] [Abstract][Full Text] [Related]
17. Comparison of cardiac sympathetic nervous function with left ventricular function and perfusion in cardiomyopathies by (123)I-MIBG SPECT and (99m)Tc-tetrofosmin electrocardiographically gated SPECT. Zhao C; Shuke N; Yamamoto W; Okizaki A; Sato J; Ishikawa Y; Ohta T; Hasebe N; Kikuchi K; Aburano T J Nucl Med; 2001 Jul; 42(7):1017-24. PubMed ID: 11438621 [TBL] [Abstract][Full Text] [Related]
18. Serial change of iodine-123 metaiodobenzylguanidine (MIBG) myocardial concentration in patients with dilated cardiomyopathy. Yamakado K; Takeda K; Kitano T; Nakagawa T; Futagami Y; Konishi T; Hamada M; Nakano T; Ichihara T Eur J Nucl Med; 1992; 19(4):265-70. PubMed ID: 1597243 [TBL] [Abstract][Full Text] [Related]
19. [Quantitative analysis of 123I-metaiodobenzylguanidine myocardial imaging: assessment of its usefulness in patients with congestive heart failure]. Narita M; Kurihara T; Murano K; Usami M; Honda M Kaku Igaku; 1994 Apr; 31(4):347-58. PubMed ID: 8196231 [TBL] [Abstract][Full Text] [Related]
20. [The mechanism of giant negative T wave in electrocardiogram in patients with apical hypertrophic cardiomyopathy: evaluation with thallium-201 and iodine-123 metaiodobenzylguanidine myocardial scintigraphy]. Wang Y; Takigawa O; Handa S; Hatakeyama K; Suzuki Y Kaku Igaku; 1996 Sep; 33(9):999-1004. PubMed ID: 8921668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]